apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
Insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Strantas 50mg Injection 5 ml

Strantas 50mg Injection 5 ml, Pack of 1 INJECTION
Written By Veda Maddala , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
48 Hrs returnable
Know More
COD available

Online payment accepted

rxMedicinePrescription drug

Whats That

tooltip

Composition :

FULVESTRANT-250MG

Manufacturer/Marketer :

Intas Pharmaceuticals Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

Therapeutic Class

ANTINEOPLASTIC

Country of origin

India

Manufacturer/Marketer address

Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.
Other Info - STR0573

Author Details

Veda MaddalaDoctor badge

Written By

Veda Maddala

M Pharmacy

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 8, 2025 | 9:49 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Strantas 50mg Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Strantas 50mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Strantas 50mg Injection 5 ml.

Strantas 50mg Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Caution

Avoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.

bannner image

Pregnancy

Unsafe

Strantas 50mg Injection 5 ml is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Strantas 50mg Injection 5 ml and for two years after your last dose.

bannner image

Breast Feeding

Unsafe

Strantas 50mg Injection 5 ml is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Strantas 50mg Injection 5 ml.

bannner image

Driving

Safe if prescribed

Strantas 50mg Injection 5 ml usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Strantas 50mg Injection 5 ml.

bannner image

Liver

Caution

Strantas 50mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Strantas 50mg Injection 5 ml.

bannner image

Kidney

Caution

If you have kidney problems, inform your doctor before receiving Strantas 50mg Injection 5 ml.

bannner image

Children

Unsafe

Strantas 50mg Injection 5 ml is not recommended for children and adolescents below 18 years of age.

Product Substitutes

icon image

Keep Refrigerated. Do not freeze.

Reference

  1. https://www.medicines.org.uk/emc/product/68/pil
  2. https://www.astrazeneca.ca/content/dam/az-ca/downloads/productinformation/faslodex-consumer-information-leaflet-en.pdf
  3. https://www.medsafe.govt.nz/consumers/cmi/f/faslodex.pdf

About Strantas 50mg Injection 5 ml

Strantas 50mg Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.

Strantas 50mg Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Strantas 50mg Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Strantas 50mg Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Strantas 50mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Strantas 50mg Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Strantas 50mg Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Strantas 50mg Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Strantas 50mg Injection 5 ml.

Uses of Strantas 50mg Injection 5 ml

Breast cancer in postmenopausal women

Medicinal Benefits Mweb

Medicinal Benefits

Strantas 50mg Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Strantas 50mg Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

Directions for Use

Strantas 50mg Injection 5 ml will be administered by a healthcare professional; do not self-administer.

Side Effects of Strantas 50mg Injection 5 ml

  • Injection site reactions such as inflammation or pain
  • Weakness
  • Nausea
  • Tiredness
  • Headache
  • Joint and musculoskeletal pain

Drug Warnings

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Strantas 50mg Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Strantas 50mg Injection 5 ml and for two years after the last dose is advised. Strantas 50mg Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Strantas 50mg Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Strantas 50mg Injection 5 ml.

Drug-Drug Interactions Checker List

  • TAMOXIFEN

Habit Forming

No

Diet & Lifestyle Advise

  • Avoid fried and processed foods.
  • Include fibre-rich foods such as whole grains, fruits, and vegetables in your diet.
  • Avoid refined carbohydrates that are high in sugars.
  • Replace animal proteins (like eggs, fish, and meat) with vegetable protein sources (nuts, seeds, and beans).
  • Avoid drinking excess alcohol or caffeinated drinks, as they can worsen the symptoms.
  • Maintain a healthy weight and do moderate exercise regularly.
  • Avoid smoking and alcohol intake.

Strantas 50mg Injection 5 ml Substitute

Substitutes safety advice

Have a query?

Buy best Neoplastic Disorders products by